This short, self-paced e-learning module will complement a project developed by ECDC in 2023 on vaccine acceptance (Effective communication around the benefit and risk balance of vaccines). The course will be based on the final outputs of the project. It will synthesise project findings and showcase identified good practices in vaccine communications.
An e-learning course aimed at understanding and addressing online vaccination misinformation. It is designed to support public health practitioners and risk communicators in fighting the spread of vaccination misinformation on social media and other digital platforms.
This protocol presents a common updated methodology to estimate vaccine effectiveness (VE) for COVID-19, using established health data registries in participating European Union and European Economic Area (EU/EEA) countries.
This core protocol for ECDC studies of VE against hospitalisation with SARI laboratory-confirmed with SARS-CoV-2 or with influenza, version 3.0, represents an update to the main elements for a multi-country hospital-based study of COVID-19 vaccine effectiveness in patients hospitalised with SARI, initially published as version 1.0 [5], updated to version 2.0 [6].
The COVID-19 pandemic has shown, like never before, that risk communication, community engagement and infodemic management (RCCE-IM) is at the heart of effective health emergency response.
This generic protocol for ECDC studies describes the design and methods for a prospective multi-country cohort study of hospital-based healthcare workers (HCWs) to evaluate the effectiveness of COVID-19 vaccine in preventing laboratory-confirmed SARS-CoV-2 infection.
Influenza is a disease of public health importance due to the substantial seasonal morbidity and mortality and the high pandemic potential of its aetiologic agents, influenza viruses.